This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 2003
Title: Margit Wissenbach - Innovator in Peptide Nucleic Acid Research
Introduction
Margit Wissenbach is a distinguished inventor based in Copenhagen, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of novel drugs aimed at combating infectious microorganisms.
Latest Patents
Margit holds a patent for "Modified peptide nucleic acid (PNA) molecules." This invention relates to innovative drugs that can be utilized in the fight against infectious bacteria. Specifically, it involves peptide nucleic acid (PNA) sequences that are enhanced by conjugating cationic peptides to the PNA moiety. This modification results in PNA molecules that exhibit improved anti-infective properties.
Career Highlights
Throughout her career, Margit has focused on advancing the understanding and application of peptide nucleic acids in medical science. Her work has the potential to lead to breakthroughs in treating bacterial infections, which are a significant global health concern.
Collaborations
Margit has collaborated with notable professionals in her field, including Peter Eigil Nielsen and Liam Good. These partnerships have fostered a collaborative environment that enhances research and innovation.
Conclusion
Margit Wissenbach's contributions to peptide nucleic acid research exemplify her commitment to advancing medical science. Her innovative work in developing modified PNA molecules showcases her role as a leading inventor in the fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile